An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering products of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, marketing, and customer laws, risking penalties, legal action or prison.
Service Response and Content Elimination
Based on the social media company, the platform has removed problematic content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in strengthening compliance measures.
Online Marketplace Activities
Research also discovered groups with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, glowing reviews and step-by-step guides for mixing or administering at home.
Within moments of joining one community, a vendor shared contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, posts show black plastic packages with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her team has already encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly serious medical dangers”.
